Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
0.589
-0.035 (-5.58%)
At close: Apr 28, 2026, 4:00 PM EDT
0.580
-0.009 (-1.54%)
Pre-market: Apr 29, 2026, 8:54 AM EDT
Galmed Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -10.31 | -7.52 | -6.91 | -17.87 | -32.47 | |
| Depreciation & Amortization | - | 0.08 | 0.03 | 0.04 | 0.04 | |
| Loss (Gain) From Sale of Investments | 2.56 | 1.14 | 0.03 | 0.52 | 0.08 | |
| Stock-Based Compensation | 0.55 | 0.53 | 0.89 | 1.3 | 1.89 | |
| Other Operating Activities | -0.02 | 0.61 | -0.31 | -0.04 | 0.01 | |
| Change in Accounts Receivable | 0.24 | -0.19 | 0.35 | 0.3 | -0.31 | |
| Change in Accounts Payable | 0.7 | -0.57 | -0.68 | -2.31 | -2.18 | |
| Change in Other Net Operating Assets | -0.02 | 0.04 | 0.47 | -0.44 | 0.04 | |
| Operating Cash Flow | -6.32 | -5.88 | -6.14 | -18.5 | -32.89 | |
| Capital Expenditures | - | - | - | -0 | -0.01 | |
| Investment in Securities | -3.38 | -0.86 | 0.8 | 17.57 | 11.47 | |
| Other Investing Activities | - | -0.25 | - | - | -0 | |
| Investing Cash Flow | -3.38 | -1.11 | 0.8 | 17.56 | 11.46 | |
| Issuance of Common Stock | 9.03 | 8.79 | 6.19 | 0.07 | 17.37 | |
| Financing Cash Flow | 9.03 | 8.79 | 6.19 | 0.07 | 17.37 | |
| Net Cash Flow | -0.66 | 1.8 | 0.85 | -0.87 | -4.06 | |
| Free Cash Flow | -6.32 | -5.88 | -6.14 | -18.51 | -32.9 | |
| Free Cash Flow Per Share | -1.47 | -6.32 | -26.59 | -132.48 | -240.78 | |
| Levered Free Cash Flow | -3.83 | -4.42 | -3.63 | -12.16 | -21.08 | |
| Unlevered Free Cash Flow | -3.78 | -4.04 | -3.63 | -12.16 | -21.08 | |
| Change in Working Capital | 0.91 | -0.73 | 0.13 | -2.45 | -2.45 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.